Skip to main content
Back to General Catalyst

General Catalyst's Life Science Portfolio

Browse 3 Life Science companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Life Science Companies
3
Total Funding in Life Science
$59.1M

Life Science Portfolio Companies (3)

Export
BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

19,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio